Previous studies reported that exposure of NMOSD‐targeted cell astrocytes to NMO‐IgG would induce chemoattractant chemokine ligand 2 (CCL2) expression to increase or release.14, 17. The gene discussed is CCL2; the disease is neuromyelitis optica.